Kamada Ltd.

Kamada is focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

Bank Name Kamada Ltd.
Stock Exchange NASDAQ
Symbol KMDA
Sector Healthcare
Industry Major Pharmaceuticals
Country United States
World Region Amarica
Chairman
CEO Mr. Amir London
Employees 413
Website www.kamada.com
Registered Year 1990

UpdateContent
UpdateContent
UpdateContent